Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low‐dose busulfan and cyclophosphamide as conditioning
Authors:
- 6 December 2005
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 46 (4) , 496-500
Abstract
Seventeen patients with Fanconi anemia (FA) underwent allogeneic bone marrow transplantation (BMT) from matched related donors (MRD) between January 1999 and June 2003. Median age at BMT was 11 years. Conditioning regimen consisted of low-dose cyclophosphamide (CY; 40 mg/kg) and busulfan (BU; 6 mg/kg) with the addition of lymphoglobulin (20 mg/kg) in two patients. Graft-versus-host disease (GVHD) prophylaxis included cyclosporine A (CsA) and methotrexate (MTX; 5 mg/m2 at day 1, 3, 6). All patients engrafted (for an absolute neutrophil count >0.5 × 109/L) after a median time of 12 days (range 10–16 days). Fourteen patients (82%) had sustained grafts, whereas three others (18%) rejected grafts between day +39 and +80 after transplantation. Two of them are still alive after successful second PBSC transplantation and one died. Acute and chronic GVHD occurred in 23% and 13% of patients, respectively. With a median follow-up of 16 months (range 3–53 months), survival rate was 72% and Karnofsky score was at least 90%. The low-dose BU/CY regimen, in FA patients allografted from an HLA-matched related donor, allowed engraftment with relative low toxicity. Early graft failure (GF) remains a problem and may require modification of this regimen. Pediatr Blood Cancer 2006, 46:496–500.Keywords
This publication has 24 references indexed in Scilit:
- Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutationsJournal of Human Genetics, 2003
- Rejection of the second allogeneic graft in a child with Fanconi anemia reversed by antilymphocyte globulin and donor lymphocyte infusionThe Hematology Journal, 2003
- Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioningBone Marrow Transplantation, 1999
- Primary Treatment of Acquired Aplastic Anemia: Outcomes with Bone Marrow Transplantation and Immunosuppressive TherapyAnnals of Internal Medicine, 1997
- FANCONI'S ANAEMIA AND ITS VARIABILITYBritish Journal of Haematology, 1993
- Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9Nature Genetics, 1992
- Leukemia and preleukemia in Fanconi anemia patientsCancer Genetics and Cytogenetics, 1991
- Bone Marrow Transplantation in Fanconi AnaemiaBritish Journal of Haematology, 1980
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974